• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

COVID-19 lockdowns associated with increased quiet time and less spoken communication for children with cochlear implants

byDavy LauandAlex Chan
March 1, 2021
in Chronic Disease, Infectious Disease, Pediatrics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. During the COVID-19 pandemic lockdowns, schoolchildren with cochlear implants were exposed to more quiet time and less spoken communication, with a speech:quiet ratio of 0.9:1.0 during the lockdowns, compared to a 1.6:1.0 ratio prior to lockdowns.

2. Children with fewer household members did not experience less spoken communication, but experienced more quiet time, with a 0.15 daily hour decrease in quiet time per increase in household by 1 individual.

Evidence Rating Level: 2 (Good)

Study rundown: The COVID-19 pandemic resulted in the emergency closure of schools, leaving children to learn and socialize from the confines of their own homes. Not only has this impacted psychosocial health, as evidenced by the 350% increase in a kids mental health helpline, but the lack of socialization has limited conversational opportunities for children relying on hearing devices. Specifically, hearing devices like cochlear implants contribute significantly to language development, when they are used on a consistent basis. To gauge any changes in sound exposure and spoken communication due to the pandemic, the current study analyzed data from cochlear implants of the same cohort of schoolchildren, both before and during the lockdowns. This data included records of the type, level, and duration of sound input from the children’s environment. However, speech from conversations and from electronic media could not be distinguished in the data. The results showed that although the usage of cochlear implants was similar to pre-lockdown periods, the children received quieter sound inputs overall and reduced exposure to speech. In particular, children with fewer household members experienced a greater percentage of daily quiet time.

Click to read this article in JAMA Otolaryngology- Head & Neck Surgery

Relevant Reading: Early Hearing Detection and Vocabulary of Children With Hearing Loss

RELATED REPORTS

Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial

Selective serotonin reuptake inhibitors do not affect cognitive function through breastmilk

Exposure to components of fine particulate matter is associated with risk of autism spectrum disorder

In-Depth [prospective cohort]: The study population consisted of 45 schoolaged children from Ontario, Canada, who used cochlear implants. The mean ± SD age was 7.7 ± 5.0 years, with 51.1% girls, and 64.4% using bilateral implants. Data from the implants were considered pre-COVID-19 lockdown between February 1 and March 15, 2020, whereas the peri-COVID-19 lockdown period lasted until early July. When analyzing the levels of sound input, there was a slight increase during the peri-COVID-19 period in daily hours of 40-49 dBA input (0.26 h, 95% CI 0.03-0.55 h). As well, there was a decrease in input at 60-69 dBA (-0.49 h, 95% CI -0.21 to -0.8 h) and 70-79 dBA (-1.70 h, 95% CI -1.42 to -1.99 h). Furthermore, there was more time spent in quiet (0.76 h, 95% CI 0.27-1.26 h), and less time spent in speech alone versus speech with competing background noise (-1.38 h, 95% CI -0.88 to -1.87 h). Overall, during the pre-COVID-19 period, children were exposed 1.6 times more to speech than to quiet (4.27 h versus 2.73 h daily), whereas during the peri-COVID-19 period, children were exposed to speech 0.9 times that of quiet exposure (3.34 h versus 3.50 h daily). Children with fewer household members did not experience less exposure to speech, but did experience more quiet time, with an estimated decrease ± standard error of 0.15 ± 0.17 daily hour of quiet time per 1 individual increase.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: pediatrics
Previous Post

2 Minute Medicine Rewind March 1, 2021

Next Post

ACEi and ARB use not associated with increased risk of COVID-19 hospitalization or mortality

RelatedReports

Parents of children with autism report greater difficulty accessing health care
Chronic Disease

Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial

December 22, 2025
Adolescent mothers in protective care more likely to have their children placed in care
Neurology

Selective serotonin reuptake inhibitors do not affect cognitive function through breastmilk

November 24, 2025
2 Minute Rewind November 29, 2021
Chronic Disease

Exposure to components of fine particulate matter is associated with risk of autism spectrum disorder

October 27, 2025
Few high school students, young adults get HIV testing
Weekly Rewinds

2 Minute Medicine Rewind August 18, 2025

August 24, 2025
Next Post
UTI associated with increased risk of preeclampsia

ACEi and ARB use not associated with increased risk of COVID-19 hospitalization or mortality

Initial data on the viability of SARS-CoV-2 in aerosol and on surfaces

Dexamethasone decreased mortality in hospitalized COVID-19 patients

Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

No difference in safety or efficacy of low-dose alteplase for treatment of lacunar acute ischemic stroke

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Contemporary medical therapy for heart failure across the ejection fraction spectrum: The OPTIPHARM-HF registry
  • Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial
  • Weekly islatravir plus lenacapavir maintains HIV virologic suppression
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.